Kingworld Medicines Group Limited (HKG:1110)

Kingworld Medicines Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	230.54	235.3	173.68	242.16	187.93	250.82
Short-Term Investments	14.31	-	-	-	-	0.09
Trading Asset Securities	10	14.3	20.35	14.01	10.48	10.55
Cash & Short-Term Investments	254.85	249.6	194.03	256.17	198.41	261.46
Cash Growth	-15.64%	28.64%	-24.26%	29.11%	-24.12%	102.97%
Accounts Receivable	157.16	154.81	152.53	183.18	237.83	246.19
Other Receivables	31.06	42.63	79.21	48.61	37.89	46.45
Receivables	195.17	202.84	236.49	236.64	280.1	296.89
Inventory	112.74	120.22	117.63	84.76	106.74	130.22
Other Current Assets	20.45	35.11	40.47	46.75	54.41	26.17
Total Current Assets	583.21	607.77	588.62	624.32	639.66	714.75
Property, Plant & Equipment	429.06	423.71	385.72	299.89	209.94	167.89
Long-Term Investments	172.89	167.37	152.01	133.82	138.04	133.78
Goodwill	90.69	90.69	90.69	90.69	90.69	90.69
Other Intangible Assets	-	-	-	0.13	13.7	27.27
Other Long-Term Assets	124.27	126.03	120.62	114.5	121.8	121
Total Assets	1,400	1,416	1,338	1,263	1,214	1,255
Accounts Payable	111.74	168.32	148.66	138.79	106.1	101.54
Accrued Expenses	8.2	42.55	38	7.46	10.87	15.94
Current Portion of Long-Term Debt	259.9	225.66	191.66	271.29	229.92	296.54
Current Portion of Leases	6.43	4.36	6.37	8.01	7.58	8
Current Income Taxes Payable	1.33	10.86	15.38	16.51	11.9	6.62
Current Unearned Revenue	86.13	59.93	57.17	57.54	71.73	56.5
Other Current Liabilities	36.4	3.19	6.29	42.16	35.52	70.52
Total Current Liabilities	510.14	514.87	463.53	541.74	473.62	555.65
Long-Term Debt	153.86	161.95	150.47	-	-	-
Long-Term Leases	14.29	10.47	5.93	11.39	1.45	1.24
Long-Term Unearned Revenue	-	-	-	0.6	-	-
Long-Term Deferred Tax Liabilities	22.83	22.75	18.37	15.42	18.12	19.98
Total Liabilities	701.11	710.04	638.3	569.15	493.2	576.86
Common Stock	53.47	53.47	53.47	53.47	53.47	53.47
Additional Paid-In Capital	-	139.41	139.41	139.41	152.7	152.7
Retained Earnings	-	512.26	490.49	466.31	443.57	416.55
Comprehensive Income & Other	562.95	-65.35	-64.33	-43.61	-32.84	-30.92
Total Common Equity	616.42	639.79	619.03	615.58	616.9	591.8
Minority Interest	82.59	65.74	80.32	78.64	103.74	86.71
Shareholders' Equity	699.01	705.53	699.35	694.22	720.63	678.51
Total Liabilities & Equity	1,400	1,416	1,338	1,263	1,214	1,255
Total Debt	434.48	402.44	354.43	290.68	238.96	305.78
Net Cash (Debt)	-179.63	-152.84	-160.4	-34.51	-40.55	-44.31
Net Cash Per Share	-0.32	-0.27	-0.27	-0.06	-0.07	-0.07
Filing Date Shares Outstanding	574.48	589.6	592.45	622.5	622.5	622.5
Total Common Shares Outstanding	574.48	589.6	592.45	622.5	622.5	622.5
Working Capital	73.07	92.9	125.08	82.58	166.03	159.09
Book Value Per Share	1.07	1.09	1.04	0.99	0.99	0.95
Tangible Book Value	525.73	549.1	528.34	524.75	512.5	473.84
Tangible Book Value Per Share	0.92	0.93	0.89	0.84	0.82	0.76
Land	-	15.81	15.22	7.55	6.98	-
Buildings	-	271.9	24.26	24.26	24.26	24.26
Machinery	-	95.81	93.84	89.36	78.61	70.21
Construction In Progress	-	0.6	204.11	116.33	36.15	3.27
Leasehold Improvements	-	21.43	20.88	20.66	18.37	16.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.